Chemotherapy and Tumor Evolution Shape Pancreatic Cancer Recurrence after Resection
- PMID: 32482663
- DOI: 10.1158/2159-8290.CD-20-0359
Chemotherapy and Tumor Evolution Shape Pancreatic Cancer Recurrence after Resection
Abstract
Most patients with pancreatic cancer who undergo curative resection and systemic chemotherapy still relapse with local or systemic recurrence. In this issue, Sakamoto and colleagues use advanced genomic tools to investigate the evolutionary origins of pancreatic cancer recurrence and discover an increased mutational burden that might be promoted by therapeutic intervention and might provide an opportunity for therapeutic intervention.See related article by Sakamoto et al., p. 792.
©2020 American Association for Cancer Research.
Comment on
-
The Evolutionary Origins of Recurrent Pancreatic Cancer.Cancer Discov. 2020 Jun;10(6):792-805. doi: 10.1158/2159-8290.CD-19-1508. Epub 2020 Mar 19. Cancer Discov. 2020. PMID: 32193223 Free PMC article.
References
-
- Sakamoto H, Attiyeh MA, Gerold JM, Makohon-Moore AP, Hayashi A, Hong J, et al. The evolutionary origins of recurrent pancreatic cancer. Cancer Discov. 2020;10:792–805.
-
- Jamal-Hanjani M, Wilson GA, McGranahan N, Birkbak NJ, Watkins TBK, Veeriah S, et al. Tracking the evolution of non-small-cell lung cancer. N Engl J Med. 2017;376:2109–21.
-
- Yates LR, Knappskog S, Wedge D, Farmery JHR, Gonzalez S, Martincorena I, et al. Genomic evolution of breast cancer metastasis and relapse. Cancer Cell. 2017;32:169–84.
-
- Turajlic S, Xu H, Litchfield K, Rowan A, Chambers T, Lopez JI, et al. Tracking cancer evolution reveals constrained routes to metastases: TRACERx renal. Cell. 2018;173:581–94.
-
- Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature. 2010;467:1114–7.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
